Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease

Autor: Bernard, De Bruyne, Nico H J, Pijls, Bindu, Kalesan, Emanuele, Barbato, Pim A L, Tonino, Zsolt, Piroth, Nikola, Jagic, Sven, Möbius-Winkler, Sven, Mobius-Winckler, Gilles, Rioufol, Nils, Witt, Petr, Kala, Philip, MacCarthy, Thomas, Engström, Keith G, Oldroyd, Kreton, Mavromatis, Ganesh, Manoharan, Peter, Verlee, Ole, Frobert, Nick, Curzen, Jane B, Johnson, Peter, Jüni, William F, Fearon, D, Nikolic
Přispěvatelé: De Bruyne, B, Pijls, Nh, Kalesan, B, Barbato, Emanuele, Tonino, Pa, Piroth, Z, Jagic, N, M?bius Winkler, S, Rioufol, G, Witt, N, Kala, P, Maccarthy, P, Engstr?m, T, Oldroyd, Kg, Mavromatis, K, Manoharan, G, Verlee, P, Frobert, O, Curzen, N, Johnson, Jb, J?ni, P, Fearon, Wf, Fame, 2 Trial Investigators, Cardiovascular Biomechanics
Rok vydání: 2012
Předmět:
Male
medicine.medical_specialty
medicine.medical_treatment
Myocardial Infarction
ComputingMilieux_LEGALASPECTSOFCOMPUTING
610 Medicine & health
Angiotensin-Converting Enzyme Inhibitors
Coronary Disease
Fractional flow reserve
Kaplan-Meier Estimate
Revascularization
Coronary artery disease
360 Social problems & social services
Angioplasty
Internal medicine
medicine
Humans
Myocardial infarction
Angioplasty
Balloon
Coronary

Aged
Aspirin
business.industry
Hazard ratio
Coronary Stenosis
Percutaneous coronary intervention
Drug-Eluting Stents
General Medicine
Middle Aged
medicine.disease
Adrenergic beta-1 Receptor Antagonists
Combined Modality Therapy
Surgery
Fractional Flow Reserve
Myocardial

Conventional PCI
Retreatment
Cardiology
Drug Therapy
Combination

Female
business
Platelet Aggregation Inhibitors
Follow-Up Studies
Zdroj: De Bruyne, Bernard; Pijls, Nico H J; Kalesan, Bindu; Barbato, Emanuele; Tonino, Pim A L; Piroth, Zsolt; Jagic, Nikola; Möbius-Winkler, Sven; Rioufol, Gilles; Witt, Nils; Kala, Petr; MacCarthy, Philip; Engström, Thomas; Oldroyd, Keith G; Mavromatis, Kreton; Manoharan, Ganesh; Verlee, Peter; Frobert, Ole; Curzen, Nick; Johnson, Jane B; ... (2012). Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. New England journal of medicine NEJM, 367(11), pp. 991-1001. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa1205361
The New England Journal of Medicine, 367(11), 991-1001. Massachussetts Medical Society
ISSN: 1533-4406
0028-4793
Popis: A b s t r ac t Background The preferred initial treatment for patients with stable coronary artery disease is the best available medical therapy. We hypothesized that in patients with functionally significant stenoses, as determined by measurement of fractional flow reserve (FFR), percutaneous coronary intervention (PCI) plus the best available medical therapy would be superior to the best available medical therapy alone. Methods In patients with stable coronary artery disease for whom PCI was being considered, we assessed all stenoses by measuring FFR. Patients in whom at least one stenosis was functionally significant (FFR, ≤0.80) were randomly assigned to FFR-guided PCI plus the best available medical therapy (PCI group) or the best available medical therapy alone (medical-therapy group). Patients in whom all stenoses had an FFR of more than 0.80 were entered into a registry and received the best available medical therapy. The primary end point was a composite of death, myocardial infarction, or urgent revascularization. Results Recruitment was halted prematurely after enrollment of 1220 patients (888 who underwent randomization and 332 enrolled in the registry) because of a significant between-group difference in the percentage of patients who had a primary endpoint event: 4.3% in the PCI group and 12.7% in the medical-therapy group (hazard ratio with PCI, 0.32; 95% confidence interval [CI], 0.19 to 0.53; P
Databáze: OpenAIRE